Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Children’s Sunscreens Boost EWG Recommendation Rate In 2012

This article was originally published in The Tan Sheet

Executive Summary

The Environmental Working Group says many children’s sunscreens have “safer, more effective ingredients than those in other products.” But the Personal Care Products Council questions EWG’s research, saying the group’s report “could confuse consumers and discourage them from using sunscreen.”

You may also be interested in...



Spray Sunscreen Review Heats Up As FDA Looks Into Burn Report

FDA launched an inquiry following a report that a man suffered second-degree burns after using a Banana Boat spray sunscreen from Energizer Personal Care. The firm has submitted to FDA data showing the safety and efficacy of spray sunscreens, in support of their inclusion in the final monograph.

Spray Sunscreen Review Heats Up As FDA Looks Into Burn Report

FDA launched an inquiry following a report that a man suffered second-degree burns after using a Banana Boat spray sunscreen from Energizer Personal Care. The firm has submitted to FDA data showing the safety and efficacy of spray sunscreens, in support of their inclusion in the final monograph.

In Brief

FDA softens disclaimer for green tea QHC; Formulife/Purus covers spectrum of violations; NAD refers Schick case to FTC; Genomma drops Prestige Brands board bid.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel